Greece · Delayed Price · Currency is EUR Medicon Hellas Statistics
Total Valuation
Medicon Hellas has a market cap or net worth of EUR 13.75 million. The enterprise value is 11.23 million.
| Market Cap | 13.75M |
| Enterprise Value | 11.23M |
Important Dates
The last earnings date was Wednesday, September 30, 2026.
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | Jul 13, 2026 |
Share Statistics
Medicon Hellas has 4.42 million shares outstanding.
| Current Share Class | 4.42M |
| Shares Outstanding | 4.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 5.58.
| PE Ratio | 5.58 |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | 3.63 |
| P/OCF Ratio | 2.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.49, with an EV/FCF ratio of 2.96.
| EV / Earnings | 4.56 |
| EV / Sales | 0.60 |
| EV / EBITDA | 2.49 |
| EV / EBIT | 3.69 |
| EV / FCF | 2.96 |
Financial Position
The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.41.
| Current Ratio | 5.76 |
| Quick Ratio | 4.78 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 1.95 |
| Debt / FCF | 2.32 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is 12.43% and return on invested capital (ROIC) is 14.75%.
| Return on Equity (ROE) | 12.43% |
| Return on Assets (ROA) | 5.76% |
| Return on Invested Capital (ROIC) | 14.75% |
| Return on Capital Employed (ROCE) | 10.33% |
| Weighted Average Cost of Capital (WACC) | 5.65% |
| Revenue Per Employee | 122,546 |
| Profits Per Employee | 16,207 |
| Employee Count | 152 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, Medicon Hellas has paid 294,760 in taxes.
| Income Tax | 294,760 |
| Effective Tax Rate | 10.44% |
Stock Price Statistics
The stock price has increased by +20.08% in the last 52 weeks. The beta is 0.48, so Medicon Hellas's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +20.08% |
| 50-Day Moving Average | 2.85 |
| 200-Day Moving Average | 2.70 |
| Relative Strength Index (RSI) | 65.07 |
| Average Volume (20 Days) | 7,694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicon Hellas had revenue of EUR 18.63 million and earned 2.46 million in profits. Earnings per share was 0.56.
| Revenue | 18.63M |
| Gross Profit | 13.64M |
| Operating Income | 3.04M |
| Pretax Income | 2.82M |
| Net Income | 2.46M |
| EBITDA | 4.18M |
| EBIT | 3.04M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
The company has 11.66 million in cash and 8.81 million in debt, with a net cash position of 2.85 million or 0.64 per share.
| Cash & Cash Equivalents | 11.66M |
| Total Debt | 8.81M |
| Net Cash | 2.85M |
| Net Cash Per Share | 0.64 |
| Equity (Book Value) | 21.32M |
| Book Value Per Share | 4.75 |
| Working Capital | 19.58M |
Cash Flow
In the last 12 months, operating cash flow was 5.73 million and capital expenditures -1.94 million, giving a free cash flow of 3.79 million.
| Operating Cash Flow | 5.73M |
| Capital Expenditures | -1.94M |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | -655,977 |
| Free Cash Flow | 3.79M |
| FCF Per Share | 0.86 |
Margins
Gross margin is 73.24%, with operating and profit margins of 16.33% and 13.23%.
| Gross Margin | 73.24% |
| Operating Margin | 16.33% |
| Pretax Margin | 15.16% |
| Profit Margin | 13.23% |
| EBITDA Margin | 22.44% |
| EBIT Margin | 16.33% |
| FCF Margin | 20.35% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.18%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 4.18% |
| Dividend Growth (YoY) | 15.38% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 23.32% |
| FCF Payout Ratio | 17.49% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.18% |
| Earnings Yield | 17.92% |
| FCF Yield | 27.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.
| Last Split Date | Jul 28, 2004 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Medicon Hellas has an Altman Z-Score of 2.45 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.45 |
| Piotroski F-Score | 7 |